8-K: Better Choice Company to Acquire SRx Health Solutions in All-Stock Transaction

Better Choice Company, Inc. has announced a definitive agreement to acquire SRx Health Solutions, Inc. in an all-stock transaction.

Summary

• Better Choice Company, Inc. has entered into an Arrangement Agreement to acquire SRx Health Solutions, Inc.
• The acquisition will be an all-stock transaction, with SRx becoming an indirect wholly-owned subsidiary of Better Choice.
• SRx shareholders will receive shares of Better Choice common stock or exchangeable shares of a subsidiary, at their option.
• The exchange ratio will be determined five business days before closing, based on the trailing 30-day volume weighted average price of Better Choice stock, subject to a share collar between 19,750,000 and 30,000,000 shares.
• The transaction values SRx at approximately US$80 million, assuming net debt at closing of US$43 million, subject to a two-way adjustment.
• The boards of directors of both companies have unanimously approved the transaction.
• The deal is subject to customary closing conditions, including shareholder and regulatory approvals.

Sentiment

Score: 7

Explanation: The document is positive in tone, announcing a strategic acquisition. However, it also acknowledges the risks and uncertainties associated with the transaction, which tempers the overall sentiment.

Positives

• The acquisition is expected to create synergies between the two companies.
• The all-stock nature of the deal may preserve Better Choice's cash reserves.
• The transaction has received unanimous board approval from both companies, indicating strong support.
• The option for SRx shareholders to receive exchangeable shares may provide tax benefits for some holders.

Negatives

• The transaction is subject to customary closing conditions, including shareholder and regulatory approvals, which could introduce uncertainty.
• The exchange ratio is subject to a share collar, which could result in a different number of shares being issued than initially anticipated.
• The valuation of SRx is subject to a two-way adjustment based on net debt at closing, which could impact the final price.

Risks

• The transaction is subject to shareholder and regulatory approvals, which may not be obtained.
• The exchange ratio is subject to a share collar, which could result in a different number of shares being issued than initially anticipated.
• The valuation of SRx is subject to a two-way adjustment based on net debt at closing, which could impact the final price.
• There is a risk of a material adverse effect occurring at either company before closing.
• The integration of SRx into Better Choice may present challenges.

Future Outlook

The company intends to use the updated presentation in future meetings with investors and analysts. The company also intends to file a proxy statement with the SEC for the approval of the transaction.

Management Comments

• The transaction has been unanimously approved by the boards of directors of both companies.
• Mr. Adesh Vora, SRxs Chief Executive Officer and majority stockholders have entered to a Voting Agreement with the Company.

Industry Context

This acquisition reflects a trend of consolidation in the healthcare and pharmaceutical services industry, as companies seek to expand their market presence and service offerings. It also shows a move towards all-stock transactions, which can be beneficial for companies looking to preserve cash.

Comparison to Industry Standards

• The all-stock nature of the deal is similar to other recent acquisitions in the healthcare sector, where companies are using their stock to fund growth.
• The valuation of SRx at approximately US$80 million is within the range of comparable transactions for companies of similar size and scope in the specialty pharmacy space.
• The use of a share collar in the exchange ratio is a common mechanism to manage price fluctuations between the signing and closing of the deal.
• The requirement for shareholder and regulatory approvals is standard for transactions of this nature.

Management Changes

Stakeholder Impact

• Shareholders of SRx will receive shares of Better Choice or exchangeable shares, potentially increasing their investment value.
• Shareholders of Better Choice will see a change in the company's structure and potential for growth.
• Employees of both companies may experience changes in their roles and responsibilities.
• Customers of both companies may see changes in the products and services offered.

Next Steps

• SRx will apply for an Interim Order from the Ontario Superior Court of Justice.
• SRx will convene a special meeting of securityholders to vote on the Arrangement.
• Parent will file a proxy statement with the SEC for shareholder approval.
• The parties will seek all necessary regulatory approvals.
• The transaction is expected to close after all conditions are met.

Key Dates

Keywords

acquisition, merger, all-stock transaction, healthcare, pharmacy, SRx Health Solutions, Better Choice Company, share exchange, amalgamation, NYSE American